Global CAR T-cell Therapy Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
LPI (LP Information)' newest research report, the “CAR T-cell Therapy Drug Industry Forecast” looks at past sales and reviews total world CAR T-cell Therapy Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected CAR T-cell Therapy Drug sales for 2023 through 2029. With CAR T-cell Therapy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-cell Therapy Drug industry.
This Insight Report provides a comprehensive analysis of the global CAR T-cell Therapy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CAR T-cell Therapy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR T-cell Therapy Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-cell Therapy Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-cell Therapy Drug.
The global CAR T-cell Therapy Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key CAR T-cell Therapy Drug players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-cell Therapy Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
LPI (LP Information)' newest research report, the “CAR T-cell Therapy Drug Industry Forecast” looks at past sales and reviews total world CAR T-cell Therapy Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected CAR T-cell Therapy Drug sales for 2023 through 2029. With CAR T-cell Therapy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-cell Therapy Drug industry.
This Insight Report provides a comprehensive analysis of the global CAR T-cell Therapy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CAR T-cell Therapy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR T-cell Therapy Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-cell Therapy Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-cell Therapy Drug.
The global CAR T-cell Therapy Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for CAR T-cell Therapy Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key CAR T-cell Therapy Drug players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-cell Therapy Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- CD19-targeted
- BCMA-targeted
- Lymphoma
- Multiple Myeloma
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-cell Therapy Drug Market Size 2018-2029
2.1.2 CAR T-cell Therapy Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 CAR T-cell Therapy Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 CAR T-cell Therapy Drug Market Size by Type
2.3.1 CAR T-cell Therapy Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
2.4 CAR T-cell Therapy Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-cell Therapy Drug Market Size by Application
2.5.1 CAR T-cell Therapy Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
3 CAR T-CELL THERAPY DRUG MARKET SIZE BY PLAYER
3.1 CAR T-cell Therapy Drug Market Size Market Share by Players
3.1.1 Global CAR T-cell Therapy Drug Revenue by Players (2018-2023)
3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Players (2018-2023)
3.2 Global CAR T-cell Therapy Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY DRUG BY REGIONS
4.1 CAR T-cell Therapy Drug Market Size by Regions (2018-2023)
4.2 Americas CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.3 APAC CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.4 Europe CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa CAR T-cell Therapy Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas CAR T-cell Therapy Drug Market Size by Country (2018-2023)
5.2 Americas CAR T-cell Therapy Drug Market Size by Type (2018-2023)
5.3 Americas CAR T-cell Therapy Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-cell Therapy Drug Market Size by Region (2018-2023)
6.2 APAC CAR T-cell Therapy Drug Market Size by Type (2018-2023)
6.3 APAC CAR T-cell Therapy Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-cell Therapy Drug by Country (2018-2023)
7.2 Europe CAR T-cell Therapy Drug Market Size by Type (2018-2023)
7.3 Europe CAR T-cell Therapy Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-cell Therapy Drug by Region (2018-2023)
8.2 Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL THERAPY DRUG MARKET FORECAST
10.1 Global CAR T-cell Therapy Drug Forecast by Regions (2024-2029)
10.1.1 Global CAR T-cell Therapy Drug Forecast by Regions (2024-2029)
10.1.2 Americas CAR T-cell Therapy Drug Forecast
10.1.3 APAC CAR T-cell Therapy Drug Forecast
10.1.4 Europe CAR T-cell Therapy Drug Forecast
10.1.5 Middle East & Africa CAR T-cell Therapy Drug Forecast
10.2 Americas CAR T-cell Therapy Drug Forecast by Country (2024-2029)
10.2.1 United States CAR T-cell Therapy Drug Market Forecast
10.2.2 Canada CAR T-cell Therapy Drug Market Forecast
10.2.3 Mexico CAR T-cell Therapy Drug Market Forecast
10.2.4 Brazil CAR T-cell Therapy Drug Market Forecast
10.3 APAC CAR T-cell Therapy Drug Forecast by Region (2024-2029)
10.3.1 China CAR T-cell Therapy Drug Market Forecast
10.3.2 Japan CAR T-cell Therapy Drug Market Forecast
10.3.3 Korea CAR T-cell Therapy Drug Market Forecast
10.3.4 Southeast Asia CAR T-cell Therapy Drug Market Forecast
10.3.5 India CAR T-cell Therapy Drug Market Forecast
10.3.6 Australia CAR T-cell Therapy Drug Market Forecast
10.4 Europe CAR T-cell Therapy Drug Forecast by Country (2024-2029)
10.4.1 Germany CAR T-cell Therapy Drug Market Forecast
10.4.2 France CAR T-cell Therapy Drug Market Forecast
10.4.3 UK CAR T-cell Therapy Drug Market Forecast
10.4.4 Italy CAR T-cell Therapy Drug Market Forecast
10.4.5 Russia CAR T-cell Therapy Drug Market Forecast
10.5 Middle East & Africa CAR T-cell Therapy Drug Forecast by Region (2024-2029)
10.5.1 Egypt CAR T-cell Therapy Drug Market Forecast
10.5.2 South Africa CAR T-cell Therapy Drug Market Forecast
10.5.3 Israel CAR T-cell Therapy Drug Market Forecast
10.5.4 Turkey CAR T-cell Therapy Drug Market Forecast
10.5.5 GCC Countries CAR T-cell Therapy Drug Market Forecast
10.6 Global CAR T-cell Therapy Drug Forecast by Type (2024-2029)
10.7 Global CAR T-cell Therapy Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-cell Therapy Drug Product Offered
11.1.3 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Offered
11.2.3 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-cell Therapy Drug Product Offered
11.4.3 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Offered
11.5.3 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-cell Therapy Drug Product Offered
11.6.3 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-cell Therapy Drug Market Size 2018-2029
2.1.2 CAR T-cell Therapy Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 CAR T-cell Therapy Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 CAR T-cell Therapy Drug Market Size by Type
2.3.1 CAR T-cell Therapy Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
2.4 CAR T-cell Therapy Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-cell Therapy Drug Market Size by Application
2.5.1 CAR T-cell Therapy Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
3 CAR T-CELL THERAPY DRUG MARKET SIZE BY PLAYER
3.1 CAR T-cell Therapy Drug Market Size Market Share by Players
3.1.1 Global CAR T-cell Therapy Drug Revenue by Players (2018-2023)
3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Players (2018-2023)
3.2 Global CAR T-cell Therapy Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY DRUG BY REGIONS
4.1 CAR T-cell Therapy Drug Market Size by Regions (2018-2023)
4.2 Americas CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.3 APAC CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.4 Europe CAR T-cell Therapy Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa CAR T-cell Therapy Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas CAR T-cell Therapy Drug Market Size by Country (2018-2023)
5.2 Americas CAR T-cell Therapy Drug Market Size by Type (2018-2023)
5.3 Americas CAR T-cell Therapy Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-cell Therapy Drug Market Size by Region (2018-2023)
6.2 APAC CAR T-cell Therapy Drug Market Size by Type (2018-2023)
6.3 APAC CAR T-cell Therapy Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-cell Therapy Drug by Country (2018-2023)
7.2 Europe CAR T-cell Therapy Drug Market Size by Type (2018-2023)
7.3 Europe CAR T-cell Therapy Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-cell Therapy Drug by Region (2018-2023)
8.2 Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL THERAPY DRUG MARKET FORECAST
10.1 Global CAR T-cell Therapy Drug Forecast by Regions (2024-2029)
10.1.1 Global CAR T-cell Therapy Drug Forecast by Regions (2024-2029)
10.1.2 Americas CAR T-cell Therapy Drug Forecast
10.1.3 APAC CAR T-cell Therapy Drug Forecast
10.1.4 Europe CAR T-cell Therapy Drug Forecast
10.1.5 Middle East & Africa CAR T-cell Therapy Drug Forecast
10.2 Americas CAR T-cell Therapy Drug Forecast by Country (2024-2029)
10.2.1 United States CAR T-cell Therapy Drug Market Forecast
10.2.2 Canada CAR T-cell Therapy Drug Market Forecast
10.2.3 Mexico CAR T-cell Therapy Drug Market Forecast
10.2.4 Brazil CAR T-cell Therapy Drug Market Forecast
10.3 APAC CAR T-cell Therapy Drug Forecast by Region (2024-2029)
10.3.1 China CAR T-cell Therapy Drug Market Forecast
10.3.2 Japan CAR T-cell Therapy Drug Market Forecast
10.3.3 Korea CAR T-cell Therapy Drug Market Forecast
10.3.4 Southeast Asia CAR T-cell Therapy Drug Market Forecast
10.3.5 India CAR T-cell Therapy Drug Market Forecast
10.3.6 Australia CAR T-cell Therapy Drug Market Forecast
10.4 Europe CAR T-cell Therapy Drug Forecast by Country (2024-2029)
10.4.1 Germany CAR T-cell Therapy Drug Market Forecast
10.4.2 France CAR T-cell Therapy Drug Market Forecast
10.4.3 UK CAR T-cell Therapy Drug Market Forecast
10.4.4 Italy CAR T-cell Therapy Drug Market Forecast
10.4.5 Russia CAR T-cell Therapy Drug Market Forecast
10.5 Middle East & Africa CAR T-cell Therapy Drug Forecast by Region (2024-2029)
10.5.1 Egypt CAR T-cell Therapy Drug Market Forecast
10.5.2 South Africa CAR T-cell Therapy Drug Market Forecast
10.5.3 Israel CAR T-cell Therapy Drug Market Forecast
10.5.4 Turkey CAR T-cell Therapy Drug Market Forecast
10.5.5 GCC Countries CAR T-cell Therapy Drug Market Forecast
10.6 Global CAR T-cell Therapy Drug Forecast by Type (2024-2029)
10.7 Global CAR T-cell Therapy Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-cell Therapy Drug Product Offered
11.1.3 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Offered
11.2.3 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-cell Therapy Drug Product Offered
11.4.3 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Offered
11.5.3 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-cell Therapy Drug Product Offered
11.6.3 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR T-cell Therapy Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. CAR T-cell Therapy Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 7. CAR T-cell Therapy Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 10. Global CAR T-cell Therapy Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global CAR T-cell Therapy Drug Revenue Market Share by Player (2018-2023)
Table 12. CAR T-cell Therapy Drug Key Players Head office and Products Offered
Table 13. CAR T-cell Therapy Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-cell Therapy Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global CAR T-cell Therapy Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global CAR T-cell Therapy Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas CAR T-cell Therapy Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas CAR T-cell Therapy Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC CAR T-cell Therapy Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe CAR T-cell Therapy Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa CAR T-cell Therapy Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of CAR T-cell Therapy Drug
Table 45. Key Market Challenges & Risks of CAR T-cell Therapy Drug
Table 46. Key Industry Trends of CAR T-cell Therapy Drug
Table 47. Global CAR T-cell Therapy Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global CAR T-cell Therapy Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global CAR T-cell Therapy Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Novartis Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 52. Novartis CAR T-cell Therapy Drug Product Offered
Table 53. Novartis CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 57. Gilead Sciences CAR T-cell Therapy Drug Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 62. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 67. J & J CAR T-cell Therapy Drug Product Offered
Table 68. J & J Main Business
Table 69. J & J CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 72. JW Therapeutics CAR T-cell Therapy Drug Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 77. FOSUNKite CAR T-cell Therapy Drug Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. FOSUNKite Latest Developments
Table 1. CAR T-cell Therapy Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. CAR T-cell Therapy Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 7. CAR T-cell Therapy Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 10. Global CAR T-cell Therapy Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global CAR T-cell Therapy Drug Revenue Market Share by Player (2018-2023)
Table 12. CAR T-cell Therapy Drug Key Players Head office and Products Offered
Table 13. CAR T-cell Therapy Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-cell Therapy Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global CAR T-cell Therapy Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global CAR T-cell Therapy Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas CAR T-cell Therapy Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas CAR T-cell Therapy Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC CAR T-cell Therapy Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe CAR T-cell Therapy Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa CAR T-cell Therapy Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of CAR T-cell Therapy Drug
Table 45. Key Market Challenges & Risks of CAR T-cell Therapy Drug
Table 46. Key Industry Trends of CAR T-cell Therapy Drug
Table 47. Global CAR T-cell Therapy Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global CAR T-cell Therapy Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global CAR T-cell Therapy Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Novartis Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 52. Novartis CAR T-cell Therapy Drug Product Offered
Table 53. Novartis CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 57. Gilead Sciences CAR T-cell Therapy Drug Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 62. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 67. J & J CAR T-cell Therapy Drug Product Offered
Table 68. J & J Main Business
Table 69. J & J CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 72. JW Therapeutics CAR T-cell Therapy Drug Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 77. FOSUNKite CAR T-cell Therapy Drug Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. FOSUNKite Latest Developments
LIST OF FIGURES
Figure 1. CAR T-cell Therapy Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-cell Therapy Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. CAR T-cell Therapy Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. CAR T-cell Therapy Drug Sales Market Share by Country/Region (2022)
Figure 8. CAR T-cell Therapy Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global CAR T-cell Therapy Drug Market Size Market Share by Type in 2022
Figure 10. CAR T-cell Therapy Drug in Lymphoma
Figure 11. Global CAR T-cell Therapy Drug Market: Lymphoma (2018-2023) & ($ Millions)
Figure 12. CAR T-cell Therapy Drug in Multiple Myeloma
Figure 13. Global CAR T-cell Therapy Drug Market: Multiple Myeloma (2018-2023) & ($ Millions)
Figure 14. Global CAR T-cell Therapy Drug Market Size Market Share by Application in 2022
Figure 15. Global CAR T-cell Therapy Drug Revenue Market Share by Player in 2022
Figure 16. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2018-2023)
Figure 17. Americas CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 18. APAC CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 19. Europe CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 21. Americas CAR T-cell Therapy Drug Value Market Share by Country in 2022
Figure 22. United States CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC CAR T-cell Therapy Drug Market Size Market Share by Region in 2022
Figure 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Type in 2022
Figure 28. APAC CAR T-cell Therapy Drug Market Size Market Share by Application in 2022
Figure 29. China CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. India CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Country in 2022
Figure 36. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Figure 37. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Figure 38. Germany CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. France CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Figure 46. Egypt CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 52. APAC CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 53. Europe CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 55. United States CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 56. Canada CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 57. Mexico CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 58. Brazil CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 59. China CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 60. Japan CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 61. Korea CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 63. India CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 64. Australia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 65. Germany CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 66. France CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 67. UK CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 68. Italy CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 69. Russia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 70. Spain CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 71. Egypt CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 72. South Africa CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 73. Israel CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 74. Turkey CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 76. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. CAR T-cell Therapy Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-cell Therapy Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. CAR T-cell Therapy Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. CAR T-cell Therapy Drug Sales Market Share by Country/Region (2022)
Figure 8. CAR T-cell Therapy Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global CAR T-cell Therapy Drug Market Size Market Share by Type in 2022
Figure 10. CAR T-cell Therapy Drug in Lymphoma
Figure 11. Global CAR T-cell Therapy Drug Market: Lymphoma (2018-2023) & ($ Millions)
Figure 12. CAR T-cell Therapy Drug in Multiple Myeloma
Figure 13. Global CAR T-cell Therapy Drug Market: Multiple Myeloma (2018-2023) & ($ Millions)
Figure 14. Global CAR T-cell Therapy Drug Market Size Market Share by Application in 2022
Figure 15. Global CAR T-cell Therapy Drug Revenue Market Share by Player in 2022
Figure 16. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2018-2023)
Figure 17. Americas CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 18. APAC CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 19. Europe CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa CAR T-cell Therapy Drug Market Size 2018-2023 ($ Millions)
Figure 21. Americas CAR T-cell Therapy Drug Value Market Share by Country in 2022
Figure 22. United States CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC CAR T-cell Therapy Drug Market Size Market Share by Region in 2022
Figure 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Type in 2022
Figure 28. APAC CAR T-cell Therapy Drug Market Size Market Share by Application in 2022
Figure 29. China CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. India CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Country in 2022
Figure 36. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Figure 37. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Figure 38. Germany CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. France CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2018-2023)
Figure 46. Egypt CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country CAR T-cell Therapy Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 52. APAC CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 53. Europe CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 55. United States CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 56. Canada CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 57. Mexico CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 58. Brazil CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 59. China CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 60. Japan CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 61. Korea CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 63. India CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 64. Australia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 65. Germany CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 66. France CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 67. UK CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 68. Italy CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 69. Russia CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 70. Spain CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 71. Egypt CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 72. South Africa CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 73. Israel CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 74. Turkey CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries CAR T-cell Therapy Drug Market Size 2024-2029 ($ Millions)
Figure 76. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Application (2024-2029)
